Close

At AlbaCore, we focus on the long-term. As one of Europe’s leading alternative credit specialists, we invest in private capital solutions, opportunistic and dislocated credit and structured products. 

Discover more
Close

Specialist in Asia Pacific, China, India and South East Asia and Global Emerging Market equities.

Discover more
Close

Our philosophy is very simple. We are constantly searching for high quality businesses and when we acquire them, we will work relentlessly with them to create long-term sustainable value through innovation, ESG-led and proactive asset management.

Discover more
Close

Leader in active quantitative equities across Australian equities, global equities, emerging markets and global small companies.

Backed by a unique blend of research, portfolio construction and risk management, focused on uncovering original insights and translating them into investment strategies that are active and systematic, aiming to generate alpha.

Discover more
Close

Specialists in equity portfolios in Asia Pacific, emerging markets, global and sustainable investment strategies

Discover more
Important Note Click to maximise

This is a financial promotion for The First Sentier India Strategy. This information is for professional clients only in the UK and EEA and elsewhere where lawful. Investing involves certain risks including:

  • The value of investments and any income from them may go down as well as up and are not guaranteed. Investors may get back significantly less than the original amount invested.
  • Currency risk: the strategy invests in assets which are denominated in other currencies; changes in exchange rates will affect the value of the strategy and could create losses. Currency control decisions made by governments could affect the value of the strategy's investments and could cause the strategy to defer or suspend redemptions of its shares. 
  • Indian subcontinent risk: although India has seen rapid economic and structural development, investing there may still involve increased risks of political and governmental intervention, potentially limitations on the allocation of the strategy's capital, and legal, regulatory, economic and other risks including greater liquidity risk, restrictions on investment or transfer of assets, failed/delayed settlement and difficulties valuing securities. 
  • Single country / specific region risk: investing in a single country or specific region may be riskier than investing in a number of different countries or regions. Investing in a larger number of countries or regions helps spread risk.
  • Smaller companies risk: Investments in smaller companies may be riskier and more difficult to buy and sell than investments in larger companies.

For details of the firms issuing this information and any strategies referred to, please see Terms and Conditions and Important Information.

For a full description of the terms of investment and the risks please see the Prospectus and Key Investor Information Document for each strategy. 

If you are in any doubt as to the suitability of our funds for your investment needs, please seek investment advice.

FSSA Investment Managers - India - Monthly Manager Views

Undiscounted change

At a team discussion last month to track management and board changes across our investment universe, a notification on the stock exchanges piqued our interest. Mr Aditya Puri, who had only recently retired as the CEO of HDFC Bank, had joined the board of a small, unlisted pharmaceutical company, Stelis Biopharma. Given Mr Puri’s remarkable leadership at HDFC Bank, we dug deeper into his new role. In addition to his board role at Stelis, he had accepted the position of an advisor to the broader Strides Group. Over the following weeks, we spoke to the CEOs of various Strides Group companies, their competitors, ex-employees and engaged with Mr Arun Kumar, the group’s founder and majority owner. He has a track record of creating significant shareholder value through organic growth and mergers & acquisitions (M&A). We gained confidence that Solara Active Pharma Sciences, a group company, is strongly positioned to capitalise on the opportunities arising from the changes to pharmaceutical supply chains after repeated disruptions in recent years. We believe the growth opportunity ahead of it and its valuations are attractive. We recently purchased a holding in the company.

Our core philosophy is to back people. Our focus is on assessing our alignment with the owners and managers of a company, what drives them, their ambition and approach to risk and the organisational culture they are building.

We follow changes to management and ownership closely. In our experience, such changes can drive an improvement in the quality of governance, growth or capital allocation of a business. This often remains undiscounted by market participants focused on predicting the next quarter’s earnings per share (EPS), and can lead to attractive shareholder returns over the long term. We have witnessed the transformative impact of such changes in several of our holdings in recent years.

Mr Sandeep Bakshi became the CEO of ICICI Bank when its previous CEO left amidst corruption allegations. He inherited a bank with a track record of being at the forefront of every asset quality problem in India over the last two decades. In our first meeting, we were surprised that Mr Bakshi, who had spent over three decades at the group, accepted all the problems at the bank and clearly laid out his plans to revamp incentive systems, build a less hierarchical organisational culture and a more conservative approach towards risk. We gained conviction as we observed that unlike previous crises, the bank’s balance sheet and competitive position had strengthened during recent disruptions. Based on its opportunity to gain substantial market share from inefficient state owned banks, ICICI’s market-leading deposit franchise and attractive valuations of 2x Price/Book (P/B), it became the largest holding of the fund.

In 2015, we purchased a toehold position in Mphasis Limited, a mid-sized IT services company, which was then majority-owned by Hewlett-Packard (HP). HP had indicated its intention of selling its majority stake, given its own organisational changes. Due to the lack of support from its owner, Mphasis’ growth was weak. It was valued attractively at 11x forward price/earnings (P/E) and paid a 5% dividend yield. We were aware that under a new owner and CEO, there was potential for an improvement in the company’s growth and its valuation multiples. Subsequently, Blackstone Group acquired HP’s majority stake and appointed Nitin Rakesh, an experienced industry executive, as its new CEO. In our meetings, Mr Rakesh explained his strategy of hiring talent which could scale up the fast-growing digital services business and entering new markets to accelerate growth. In the four years since Mr Rakesh was appointed, Mphasis has grown its EPS at 14.4% compound annual growth rate (CAGR) compared to a marginal decline in EPS during the previous four years, and its valuation has re-rated from 11x to 27x forward P/E. We have remained shareholders through this period.

Often, the changes underway are not straightforward, as we saw in the case of Mahindra Lifespaces and Tata Consumer Products. Mahindra Lifespaces is a developer of residential property and industrial parks, owned by the 2021Mahindra Group. Residential buyers are rapidly shifting from poor-quality local developers to reputed companies as industry regulations become more stringent. Mahindra Lifespaces had not capitalised on this tailwind due to a weak project development pipeline. We purchased a holding when its parent company recognised the problems and laid out their intent to make changes. But execution remained weak under a new CEO they appointed and she left after two years. Finally, Arvind Subramaniam, an external hire, was appointed its new CEO last year. He has ramped up land acquisition and new project launches — the company finally appears to be realising its growth potential. We experienced a similar journey at Tata Consumer Products, which operates the Tata Tea and Tetley brands. When we purchased a holding in 2013, we had expected the company to exit poorly performing global businesses and focus on the fast growing and more profitable domestic business. But under two new CEOs appointed over six years, change took place slowly. It was only after Mr Chandrasekaran was appointed chairman of its parent, Tata Sons, and Mr Sunil D’Souza (ex-CEO of Whirlpool India) was appointed CEO of Tata Consumer Products, that there was a concerted effort to exit underperforming global markets and gain scale in the more attractive domestic business. We sold our holding when its valuation rose to over 50x forward P/E, as these changes were reflected in its performance.

The common factors among these cases are that each company is a fundamentally strong business, with the potential to generate high returns on capital and a long runway for growth. In some cases, the changes took longer than we anticipated. But backing the right people to do the right thing has always held us in good stead.

Performance Commentary

The fund’s performance gained in June 2021. The key contributors and detractors were:

Annual Performance (% in EUR) to 30 June 2021

These figures refer to the past. Past performance is not a reliable indicator of future results. For investors based in countries with currencies other than USD, the return may increase or decrease as a result of currency fluctuations.

Source for fund - Lipper IM / First Sentier Investors (UK) Funds Limited. Performance data is calculated on a net basis by deducting fees incurred at fund level (e.g. the management fee and other fund expenses), save that it does not take account of initial charges or switching fees (if any). Income reinvested is included on a net of tax basis. Source for benchmark - MSCI, income reinvested net of tax. Since inception performance figures have been calculated from 23 August 1999.

Contributors

Mahindra CIE rose after its parent, CIE Automotive, released its five-year operating plan which highlighted significant growth opportunities for Mahindra CIE in the coming years. The parent has been increasing its stake in the company through market purchases.

Infosys Limited is expected to benefit from the acceleration in demand for digital transformation and cloud services among clients. The recent depreciation of the Indian rupee against the US dollar is also likely to support its profitability.

Mahindra Lifespaces gained following strong demand for residential property in Mumbai, its key operating market. The management has communicated its plans to accelerate the company’s growth with a revenue target of INR 25 billion in fiscal year (FY) 2025 compared to INR 7 billion in FY 2021.

Detractors

ICICI Bank declined marginally without any change to its operating performance or business outlook. The bank’s growth and return on assets have been improving consistently.

Colgate Palmolive (India) declined marginally without any major changes to its business outlook. Following several initiatives undertaken by its new CEO, Colgate has been gaining market share.

HDFC Bank was affected by continuing digital outages. The company is investing significantly to migrate its technology applications to cloud based architecture and improve recovery systems and user experience across its interfaces.

* Company data retrieved from company annual reports or other such investor reports. Financial metrics and valuations are from FactSet and Bloomberg. As at 30 June 2021 or otherwise noted.

Important Information

This document has been prepared for informational purposes only and is only intended to provide a summary of the subject matter covered and does not purport to be comprehensive. The views expressed are the views of the writer at the time of issue and may change over time. It does not constitute investment advice and/or a recommendation and should not be used as the basis of any investment decision. This document is not an offer document and does not constitute an offer or invitation or investment recommendation to distribute or purchase securities, shares, units or other interests or to enter into an investment agreement. No person should rely on the content and/or act on the basis of any material contained in this document.

This document is confidential and must not be copied, reproduced, circulated or transmitted, in whole or in part, and in any form or by any means without our prior written consent. The information contained within this document has been obtained from sources that we believe to be reliable and accurate at the time of issue but no representation or warranty, express or implied, is made as to the fairness, accuracy, or completeness of the information. We do not accept any liability whatsoever for any loss arising directly or indirectly from any use of this information.

References to “we” or “us” are references to First Sentier Investors.

In the UK, issued by First Sentier Investors (UK) Funds Limited which is authorised and regulated by the Financial Conduct Authority (registration number 143359). Registered office Finsbury Circus House, 15 Finsbury Circus, London, EC2M 7EB number 2294743. Outside the UK and the EEA, issued by First Sentier Investors International IM Limited which is authorised and regulated in the UK by the Financial Conduct Authority (registered number 122512). Registered office: 23 St. Andrew Square, Edinburgh, EH2 1BB number SCO79063.

Certain funds referred to in this document are identified as sub-funds of First Sentier Investors ICVC, an open ended investment company registered in England and Wales (“OEIC”). Following the UK departure from the European Union, the OEIC has ceased to qualify as a UCITS scheme and is instead an Alternative Investment Fund (“AIF”) for European Union purposes under the terms of the Alternative Investment Fund Managers Directive (2011/61/EU). Accordingly, no marketing activities relating to the OEIC are being carried-out by First Sentier Investors in the European Union (or the additional EEA states) and the OEIC is not available for distribution in those jurisdictions. This document does not constitute an offer or invitation or investment recommendation to distribute or purchase shares in the OEIC in the European Union (or the additional EEA states). Further information is contained in the Prospectus and Key Investor Information Documents of the OEIC which are available free of charge by writing to: Client Services, First Sentier Investors (UK) Funds Limited, PO Box 404, Darlington, DL1 9UZ or by telephoning 0800 587 4141 between 9am and 5pm Monday to Friday or by visiting www.firstsentierinvestors.com. Telephone calls may be recorded. The distribution or purchase of shares in the funds, or entering into an investment agreement with First Sentier Investors may be restricted in certain jurisdictions.

Representative and Paying Agent in Switzerland: The representative and paying agent in Switzerland is BNP Paribas Securities Services, Paris, succursale de Zurich, Selnaustrasse 16, 8002 Zurich, Switzerland. Place where the relevant documentation may be obtained: The prospectus, key investor information documents (KIIDs), the instrument of incorporation as well as the annual and semi-annual reports may be obtained free of charge from the representative in Switzerland.

First Sentier Investors entities referred to in this document are part of First Sentier Investors a member of MUFG, a global financial group. First Sentier Investors includes a number of entities in different jurisdictions. MUFG and its subsidiaries do not guarantee the performance of any investment or entity referred to in this document or the repayment of capital. Any investments referred to are not deposits or other liabilities of MUFG or its subsidiaries, and are subject to investment risk including loss of income and capital invested.

Copyright © (2021) First Sentier Investors

All rights reserved.